Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Convertible Preferred Stock^F2,F3,F1	$5.17	Mar 9, 2015	P	625,000	A	—	—	Common Stock	12,088,975	625,000	I
Warrant No. 1 (right to buy)^F3,F4	$5.295	Mar 9, 2015	P	1,800,000	A	Mar 9, 2015	Mar 9, 2025	Common Stock	1,800,000	1,800,000	I
Warrant No. 2 (right to buy)^F3,F5	$6.595	Mar 9, 2015	P	1,800,000	A	Mar 9, 2015	Mar 9, 2025	Common Stock	1,800,000	1,800,000	I

Explanation of responses

F1The Preferred Stock is convertible into common stock at any time and has no expiration date.
F2These securities are held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser, (b) Coliseum Capital Partners II, L.P. ("CCP2" and, together with CCP, the "Funds"), an investment limited partnership of which CC is general partner and for which CCM serves as investment adviser, and (c) a separate account investment advisory client of CCM (the "Separate Account"). Christopher Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of CCM and CC. Following the purchase of Series A Preferred Stock reported herein, CCP, CCP2 and the Separate Account directly owned 393,468, 88,045 and 143,487 shares of Series A Preferred Stock, respectively.
F3Each of Shackelton, Gray, CCP, CCP2, the Separate Account, CC and CCM disclaim beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.
F4The warrants are held directly by (a) CCP (b) CCP2 and (c) the Separate Account. Following the transactions reported herein, CCP, CCP2 and the Separate Account directly owned warrants to purchase 1,133,188, 253,569 and 413,243 shares of common stock, respectively, with respect to Warrant No. 1.
F5The warrants are held directly by (a) CCP (b) CCP2 and (c) the Separate Account. Following the transactions reported herein, CCP, CCP2 and the Separate Account directly owned warrants to purchase 1,133,188, 253,569 and 413,243 shares of common stock, respectively, with respect to Warrant No. 2.

Remarks

Christopher Shackelton is a director of the Issuer. As a result, the following persons may be deemed directors by deputization of the Issuer solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended: Coliseum Capital Management, LLC; Coliseum Capital, LLC; Coliseum Capital Partners, L.P.; Coliseum Capital Partners II, L.P.; and Adam Gray.